| 000 | 01743 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516004231.0 | ||
| 264 | 0 | _c20120410 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1097-9867 | ||
| 024 | 7 |
_a10.3109/10837450.2010.513986 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchellekens, Reinout C A | |
| 245 | 0 | 0 |
_aFilm coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics. _h[electronic resource] |
| 260 |
_bPharmaceutical development and technology _c |
||
| 300 |
_a40-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 |
_aColon _xphysiology |
| 650 | 0 | 4 | _aColor |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 | _aExcipients |
| 650 | 0 | 4 | _aHardness |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aLower Gastrointestinal Tract _xphysiology |
| 650 | 0 | 4 |
_aMesalamine _xadministration & dosage |
| 650 | 0 | 4 | _aPharmaceutical Preparations |
| 650 | 0 | 4 | _aPolymethacrylic Acids |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aSuspensions |
| 650 | 0 | 4 | _aTablets, Enteric-Coated |
| 700 | 1 | _aBaltink, Jan H | |
| 700 | 1 | _aWoesthuis, Ellen M | |
| 700 | 1 | _aStellaard, Frans | |
| 700 | 1 | _aKosterink, Jos G W | |
| 700 | 1 | _aWoerdenbag, Herman J | |
| 700 | 1 | _aFrijlink, Henderik W | |
| 773 | 0 |
_tPharmaceutical development and technology _gvol. 17 _gno. 1 _gp. 40-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10837450.2010.513986 _zAvailable from publisher's website |
| 999 |
_c20229274 _d20229274 |
||